US-listed shares of Inmode slide on downbeat FY, quarterly rev outlook
** US-listed shares of Israel-based medical equipment and
technology company Inmode INMD.O down 4% at about $19 in
premarket trading
** Co decreases FY24 revenue guidance to between $485 mln
-$495 mln, below avg analysts' estimate of $498.8 mln - LSEG
IBES data
** "Esthetics industry remains significantly affected by the
challenges posed by the macro-economic environment" - co
** Sees Q1 rev between $80 mln - $80.1 mln, below average
estimate of $102.2 mln
** As of last close, US-listed shares of INMD down 11% YTD
(Reporting by Saikeerthi in Bengaluru)
((Saikeerthi@thomsonreuters.com;))
Recent news on InMode
See all newsBrief: Inmode Haifa District Court Denied Sp Strategic Holdings' Request For Temporary Injunctive Relief In Its Entirety
InMode Ltd. reports results for the quarter ended June 30 - Earnings Summary
Brief: Inmode Q2 Revenue USD 95.589 Million Versus. Ibes Estimate USD 93 Million
InMode Q2 revenue beats estimates on steady U.S. demand
Brief: Steel Partners Urges Inmode Shareholders To Vote Against The Re-Election Of Dr. Hadar Ron And Against Extraordinary Special Committee Compensation At The July 30 Annual General Meeting